Login / Signup

A nanoplatform for mild-temperature photothermal and type I & II photodynamic therapy in the NIR-II biowindow.

Bing LuZhecheng ZhangYuying HuangYuehua ZhangJin WangYue DingYang WangYong Yao
Published in: Chemical communications (Cambridge, England) (2022)
In the current work, we synthesized an A-D-A smallmolecule photosensitizer, denoted as DPTTIC, and a dual PEG-functionalized pillararene, denoted as WP5-8C-2PEG, and used them to construct novel DPTTIC nanoparticles (NPs) displaying NIR II absorption. Under 980 nm-wavelength laser irradiation, DPTTIC NPs performed well in mild-temperature photothermal and type I & II photodynamic anti-tumor therapy.
Keyphrases
  • photodynamic therapy
  • fluorescence imaging
  • drug delivery
  • cancer therapy
  • drug release
  • oxide nanoparticles
  • bone marrow
  • mass spectrometry
  • mesenchymal stem cells
  • radiation therapy
  • molecularly imprinted